A China Drug Master File (DMF) is crucial for pharmaceutical companies as it facilitates regulatory compliance, ensuring product safety and quality. It streamlines the approval process for drugs in China, protects proprietary information, and enhances market access, enabling companies to efficiently navigate China’s complex regulatory landscape and expand their market presence.